ARTICLE | Clinical News
Rotarix regulatory update
March 6, 2006 8:00 AM UTC
EC approved Rotarix oral vaccine to prevent gastroenteritis due to rotavirus infection in infants. The approval triggers a $4 million milestone from GSK. AVAN is eligible for a $40 million milestone f...